MA

Milad Alucozai

North America, California, United States, San Francisco

Description

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of exp...

Investor Profile

Milad Alucozai has made 31 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (45%)
  • Series A (32%)
  • Pre Seed (13%)
  • Series B (6%)
  • Series Unknown (3%)

Country Focus

  • United States (71%)
  • United Kingdom (13%)
  • Canada (13%)
  • Spain (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
  • Medical
  • Biopharma
  • Therapeutics
  • Machine Learning
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Milad Alucozai frequently co-invest with?

First Round Capital
North America, California, United States, San Francisco
Co-Investments: 3
Builders VC
North America, California, United States, San Francisco
Co-Investments: 4
Liquid 2 Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 3
BoxOne Ventures
North America, Quebec, Canada, Montréal
Co-Investments: 3
BoxGroup
North America, New York, United States, New York
Co-Investments: 2
Fifty Years
North America, California, United States, San Francisco
Co-Investments: 4
Harmonix Fund
North America, California, United States, La Quinta
Co-Investments: 3
Bioverge
North America, California, United States, San Francisco
Co-Investments: 4
10X Capital
North America, New York, United States, New York
Co-Investments: 3

Which angels does Milad Alucozai often collaborate with?

CG
North America, Utah, United States, Salt Lake City
Shared Deals: 1
AZ
North America, California, United States, San Francisco
Shared Deals: 2
MC
North America, North Dakota, United States, Fargo
Shared Deals: 1
MS
North America, California, United States, Santa Monica
Shared Deals: 1
BS
North America, California, United States, San Francisco
Shared Deals: 1
AG
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
MD
North America, California, United States, San Francisco
Shared Deals: 2
AM
Europe, Hessen, Germany, Frankfurt
Shared Deals: 1
IH
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Milad Alucozai?

Future Fields

Edmonton, Alberta, Canada

Future Fields harnesses insect biotechnology to make sustainable recombinant proteins.

AgricultureAgTechAlternative ProteinBiotechnologyCleanTechFarmingLife Science
Series AFeb 23, 2023
Amount Raised: $11,149,087
Eigen Therapeutics

Redwood City, California, United States

Biotechnology company developing combination therapeutics for cancer

BiotechnologyLife Science
SeedDec 8, 2022
Amount Raised: $7,000,000
Arpeggio Bio

Boulder, Colorado, United States

Arpeggio builds technology to watch and learn how drugs work.

BiotechnologyHealth CareMachine LearningPharmaceuticalTherapeutics
Series ASep 7, 2022
Amount Raised: $17,000,000
Notable Labs

Foster City, California, United States

Notable Labs provides personalized drug combination testing service for cancer patients.

BiotechnologyHealth CareMedical
Series BJul 1, 2022
Character Biosciences

Jersey City, New Jersey, United States

Biopharmaceutical research and development company

BiotechnologyClinical TrialsHealth CareHealth DiagnosticsPharmaceutical
Series AMay 17, 2022
Amount Raised: $18,000,000
CytoTronics

Boston, Massachusetts, United States

CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.

Test and Measurement
SeedApr 28, 2022
Amount Raised: $9,250,000
Colossal Biosciences

Dallas, Texas, United States

Colossal is a bioscience and genetic engineering company that focuses on de-extinction of past species.

BiotechnologyGeneticsLife Science
Series AMar 9, 2022
Amount Raised: $60,000,000
Endpoint Health

Palo Alto, California, United States

Endpoint Health is a precision immunology company

Health Care
Series AFeb 9, 2022
64x Bio

San Francisco, California, United States

64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.

BiopharmaBiotechnologyGeneticsLife SciencePharmaceutical
Series AJan 19, 2022
Amount Raised: $55,000,000
Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series ADec 10, 2021